GC Cell and Checkpoint Therapeutics Announce Collaboration to Explore Synergistic Cancer Therapies

Collaboration explores the potential synergistic effects of Checkpoint’s anti-PD-L1, cosibelimab, in combination with the autologous T cell thera...

July 16, 2024 | Tuesday | News
AusperBio Therapeutics Secures $37 Million Series A Financing

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to ...

July 15, 2024 | Monday | News
Rznomics Inc. Receives Approval for Phase 1/2a Clinical Trial of RZ-004 in Australia

Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, announced that it has receive...

July 15, 2024 | Monday | News
Boehringer Ingelheim and OSE Immunotherapeutics Advance SIRPα Immuno-Oncology Program to Phase 1b Clinical Trials

Boehringer Ingelheim and OSE Immunotherapeutics SA (OSE), a clinical stage biotech company (ISIN: FR0012127173; Mnemo: OSE), announced that Boehringer wi...

July 04, 2024 | Thursday | News
CSL Behring Achieves European Milestone with First Real-World Treatments of Hemophilia B Using HEMGENIX® Gene Therapy

Global biotechnology leader CSL Behring  announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dez...

July 04, 2024 | Thursday | News
Samsung Bioepis Receives FDA Approval for PYZCHIVA® as Biosimilar to Stelara for Multiple Inflammatory Conditions

Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for PYZCHIVA&re...

July 01, 2024 | Monday | News
SNIPR Biome Secures Gates Foundation Funding to Combat Gut Infections in Pregnant Women in LMICs

SNIPR Biome, a pioneer in the development CRISPR-Cas armed phages (CAPs) to prevent and treat bacterial infections, announced today that it has received ...

June 28, 2024 | Friday | News
BioNTech and DualityBio's ADC Candidate BNT324/DB-1311 Gains FDA Fast-Track Status for Prostate Cancer

The status is based on preclinical data and data from an ongoing phase 1/2 study for BNT324/DB-1311; preliminary phase 1/2 clinical data showed anti-tu...

June 25, 2024 | Tuesday | News
Mika Health, AstraZeneca, and Daiichi Sankyo Launch "UNITE" Initiative to Enhance Breast Cancer Treatment Experience

Mika Health, a global digital therapeutics developer specializing in meeting the needs of cancer patients, in collaboration with AstraZenecaand Daiichi S...

June 19, 2024 | Wednesday | News
Macomics and IOR Collaborate to Advance Prostate Cancer Research with Novel Macrophage-Targeted Therapies

Laboratory of Prof. Andrea Alimonti at IOR (Institute of Oncology Research, Bellinzona, Switzerland) and Macomics to bring together expertise on myeloi...

June 19, 2024 | Wednesday | News
Junshi Biosciences' Toripalimab Approved in China for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer

Shanghai Junshi Biosciences , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of nov...

June 18, 2024 | Tuesday | News
Alvotech and Advanz Pharma Partner to Commercialize Biosimilar Eylea® Candidates in Europe

  Alvotech  a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz P...

June 18, 2024 | Tuesday | News
LIXTE Biotechnology Announces Clinical Trial Collaboration with Roche and NKI for MSI Low Metastatic Colon Cancer

LIXTE Biotechnology Holdings, Inc.  a clinical stage pharmaceutical company, today announced a collaboration with Roche and the Netherlands Cancer I...

June 17, 2024 | Monday | News
Logix Biosciences Partners with Mayo Clinic to Advance Precision Therapeutics for Allergy Relief and Infectious Diseases

-Logix Biosciences, a biopharmaceutical company focused on the discovery and development of a pipeline of precision therapeutics and companion diagnostic...

June 13, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close